Immune Checkpoint Inhibitor Toxicities-Essential Insights for the Practicing Clinician

Eric Roeland, MD, FAAHPM, FASC, Associate Professor of Medicine, Division of Hematology/Medical Oncology, School of Medicine, OHSUMolly Thomas, MD, PhD, Assistant Professor of Medicine, Division of Gastroenterology & Hepatology, Assistant Professor of Cell, Developmental & Cancer Biology, School of Medicine, OHSUCME Credit Available for all Providence ProvidersIn order to claim CME credit, please click on the following link: https://forms.office.com/r/j8tvnSw5cd (or copy & paste into your browser)Accreditation Statement: Providence Oregon Region designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1  creditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Providence Oregon Region is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.Planning Committee Disclosure: The planning committee and have indicated no relevant financial relationships with an ACCME-defined ineligible company. Their planning contributions were evidence-based and unbiased. Faculty Disclosure: Eric Roeland, MD has indicated relevant financial relationships with ACCME-defined ineligible companies: Scientific Advisory Board (Napo Pharmaceuticals); Expert Witness (Heron Pharmaceuticals); Research (Pfizer). All others in control of content have indicated no relevant financial relationship with an ACCME-defined commercial interest. All clinical content presented is evidence-based and unbiased. All financial relationships have been mitigated.Original Date: May 6, 2025End Date: May 6, 2026